Profile
David F.
Carroll worked as the Chief Accounting Officer & Senior Vice President at The Medicines Co. from 2008 to 2016.
He also worked as the Chief Financial Officer, Treasurer & Senior VP at IVERIC bio, Inc. Mr. Carroll holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Ursinus College.
Former positions of David Carroll
| Companies | Position | End |
|---|---|---|
| THE MEDICINES COMPANY | Comptroller/Controller/Auditor | 2016-05-31 |
| IVERIC BIO, INC. | Director of Finance/CFO | - |
Training of David Carroll
| Rutgers State University of New Jersey | Masters Business Admin |
| Ursinus College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Stock Market
- Insiders
- David Carroll
